Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:19 AM
Ignite Modification Date:
2025-12-25 @ 2:19 AM
NCT ID:
NCT06703034
Eligibility Criteria:
Inclusion Criteria:
* Participant aged at least 18 years
* Previously included in the COVID-ser or NOSO-COR IMMUNO study as well as in the RNIPH study (Research Not Involving Human Persons) named MIR-COVID
* Weight of 50 kg or more
Exclusion Criteria:
* Current infection symptoms
* Immunosuppression defined by: bone marrow transplant within the past 24 months, chemotherapy within the past 6 months, HIV infection with CD4 \<200/mm³ or \<15%, corticosteroid therapy for more than 2 weeks with a daily dose over 10 mg of prednisolone equivalent, immunosuppressive treatment administered within the previous 3 months (6 months for rituximab), aplasia, asplenia, or splenectomy
* Pregnant, parturient, or breastfeeding woman
* Person deprived of liberty by judicial or administrative decision
* Person receiving psychiatric care
* Person admitted to a health or social institution for purposes other than research
* Person under guardianship or curators
* Person not affiliated with a social security scheme or similar coverage
* Patient participating in another ongoing interventional research study at inclusion"
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06703034
Study Brief:
Protocol Section:
NCT06703034